References
- de la Fuente J., Prieto I., Albo C., Sopena B., Somolinos N., Martinez C. Plasma cell myeloma presented as myelomatous meningitis. Eur. J. Haematol. 1994; 53: 244–245
- Costello R. T., Arnoulet C., Azulay J. P., Gastaut J. A., Sainty D., Bouabdallah R. Identification of a myeloma variant with aggressive biological and clinical characteristics: “Early” plasma cell meningitis. Am. J. Hematol. 1997; 56: 295–296
- Turhal N., Henehan M. D., Kaplan K. L. Multiple myeloma: A patient with unusual features including intracranial and meningeal involvement, testicular involvement, organomegaly, and plasma cell leukemia. Am. J. Hematol. 1998; 57: 51–56
- Oda K., Egawa H., Okuhara T., Sakai A., Hyohdou H., Tanaka H., Kuramoto A. Meningeal involvement in Bence Jones multiple myeloma. Cancer 1991; 67: 1900–1902
- Veinstein A., Brizard A., Randriamalala E., Babin P., Preudhomme J. L., Guilhot F. Central nervous system relapses after autologous stem cell transplantation for myeloma. Report of two cases. Hematol. Cell Ther 1997; 39: 327–330
- Ardiet C., Tranchand B., Biron P., Rebattu P., Philip T. Pharmacokinetics of high‐dose intravenous mel‐phalan in children and adults with forced diuresis. Cancer Chemothe,. Pharmacol. 1986; 16: 300–305
- Gouyette A., Hartmann O., Pico J. L. Pharmacokinetics of high‐dose melphalan in children and adults. Cancer Chemother. Phannacol. 1986; 16: 184–189